Atrial-specific drugs: The way to treat atrial fibrillation?

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 12, 2004, Pages 1451-1452

  Vos, Marc A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2' (4 METHOXYPHENYLACETAMIDOMETHYL) N [2 (3 PYRIDYL)ETHYL] 2 BIPHENYLCARBOXAMIDE; ANILIDE; ANTIARRHYTHMIC AGENT; AZD 7009; C 9356; DOFETILIDE; IBUTILIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; NIP 142; POTASSIUM CHANNEL BLOCKING AGENT; RSD 1235; S 0100176; S 9946; S 9947; S 9948; S 9949; S 9950; S 9951; SOTALOL; UNCLASSIFIED DRUG;

DRUG MECHANISM; DRUG SPECIFICITY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HISTOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; TORSADE DES POINTES; ULTRARAPID INWARDLY RECTIFYING POTASSIUM CHANNEL;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEART CONDUCTION SYSTEM; HUMANS;

EID: 10944234940     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04569.x     Document Type: Editorial

References (16)

1. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E: Pharmacology of cardiac potassium channels. Cardiovasc Res 2004;62:9-33.
2. + current similar to Kv1.5 cloned channel currents. Circ Res 1993;73:1061-1076.
3. + current in canine atrial myocytes. Circ Res 2003;93:744-751.
4. Belardinelli L, Antzelevitch C, Vos MA: Assessing predictors of drug induced torsade de pointes. Trends Pharmacol Sci 2003;24:619-625.
5. Vos MA: Preclinical evaluation of anti-arrhythmic drugs: New ones should be safe to be successful. J Cardiovasc Electrophysiol 2001;12:1034-1036.
6. KACH, class Ic drugs and beta blockers in pigs. Med Sci Monit 2004;10:BR221-228.
7. Decher N, Pirard B, Bundis F, Peukert S, Baringhaus KH, Busch AE, Steinmeyer K, Sanguinetti MC: Molecular basis for Kv1.5 block. J Biol Chem 2004;279:394-400.
8. Goldstein RN, Khrestian C, Carlsson L, Waldo AL. AZD7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. J Cardiovasc Electrophysiol 2004;15:1444-1450.
9. Yue L, Wang Z, Rindt H, Nattel S: Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium. J Physiol 2000;527(Pt 3):467-478.
10. Gogelein H, Brendel J, Steinmeyer K, Strubing C, Picard N, Rampe D, Kopp K, Busch AE, Bleich M: Effects of the atrial anti-arrhythmic drug AVE0118 on cardiac ion channels. Naunyn Schmiedebergs Arch Pharmacol 2004;370:183-192.
11. + channel Kv1.5 current. Life Sci 2001;68:2017-2024.
12. Feng J, Yue L, Wang Z, Nattel S: Ionic mechanisms of regional action potential heterogeneity in the canine right atrium: Circ. Res 1998;83:541-551.
13. Li D, Zhang L, Kneller J, Nattel S: Potential ionic mechanisms for repolarisation differences between canine right and left atrium. Circ Res 2001;88:1168-1171.
14. Blaauw Y, Gogelein H, Tieleman RG, van Hunnik A, Schotten U, Allessie MA: "Early" class III drugs for the treatment of atrial fibrillation. Circulation 2004;110:1717-1724.
15. Nagasawa H, Fujiki A, Fujikura N, Matsuda T, Yamashita Inoue H: Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter. Circ J 2002;66:185-191.
16. Li D, Benardeau A, Nattel S: Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation 2000;102:104-112.